TargetingOne
Latest round
- Series B
Last raised
- Jan 2021
Total raised
- $23M
Investors
- 4
About TargetingOne
Founded in 2015 and based in Beijing, China, TargetingOne is a biotech company that focuses on the development of micro-droplet digital PCR systems and in vitro diagnostic reagents. It has service centres in Hunan, Fujian, Guangdong, Henan, Liaoning, and Shanghai. The company acquired certifications such as ISO9001 and ISO14001. It has obtained more than 100 patents. The company mainly provides equipment, reagents, and consumables. The equipment includes digital PCR platforms, nucleic acid extraction instruments, and PCR amplification instrument. Reagents include human EGFR (Epidermal Growth Factor Receptor) gene mutation detection and virus rapid extraction. Consumables include disposable virus sampling tubes and digital PCR consumables. The company's products are used in fields such as tumours, genetic diseases and infectious diseases. The company generates revenue by providing droplet digital PCR (Polymerase Chain Reaction), droplet technology platform, non-invasive prenatal testing, and liquid biopsy. The company will use the strategic investment to accelerate the company's clinical registration of digital PCR and molecular POCT series reagent products.
Who invested in TargetingOne
4 investors across 1 round
See all investors in TargetingOne
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 7, 2021
Amount
$23M
Investors
Questions about TargetingOne
Who invested in TargetingOne?
TargetingOne has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TargetingOne raised?
TargetingOne has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did TargetingOne last raise money?
TargetingOne's most recent round on record is a Series B, in Jan 2021.
What does TargetingOne do?
Founded in 2015 and based in Beijing, China, TargetingOne is a biotech company that focuses on the development of micro-droplet digital PCR systems and in vitro diagnostic reagents.
Where is TargetingOne headquartered?
TargetingOne is headquartered in Beijing, China.
Which VCs invest in companies like TargetingOne?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at TargetingOne's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like TargetingOne? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.